COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Abstract Background To examine COVID-19 vaccination and HIV transmission among persons who inject drugs (PWID) during the COVID-19 pandemic (2020-2022) in New York City (NYC). Methods Two hundred and seventy five PWID were recruited from October 2021 to September 2022. A structured questionnaire was...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Buch |
Veröffentlicht: |
BMC,
2023-05-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_0b2d77a2515b46cbb0ed69fbe8a5b19f | ||
042 | |a dc | ||
100 | 1 | 0 | |a Don C. Des Jarlais |e author |
700 | 1 | 0 | |a Chenziheng Allen Weng |e author |
700 | 1 | 0 | |a Jonathan Feelemyer |e author |
700 | 1 | 0 | |a Courtney McKnight |e author |
245 | 0 | 0 | |a COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City |
260 | |b BMC, |c 2023-05-01T00:00:00Z. | ||
500 | |a 10.1186/s12954-023-00791-0 | ||
500 | |a 1477-7517 | ||
520 | |a Abstract Background To examine COVID-19 vaccination and HIV transmission among persons who inject drugs (PWID) during the COVID-19 pandemic (2020-2022) in New York City (NYC). Methods Two hundred and seventy five PWID were recruited from October 2021 to September 2022. A structured questionnaire was used to measure demographics, drug use behaviors, overdose experiences, substance use treatment history, COVID-19 infection, vaccination, and attitudes. Serum samples were collected for HIV, HCV, and SARS-CoV-2 (COVID-19) antibody testing. Results Participants were: 71% male, the mean age was 49 (SD 11), 81% reported at least one COVID-19 immunization, 76% were fully vaccinated and 64% of the unvaccinated had antibodies for COVID-19. Self-reported injection risk behaviors were very low. HIV seroprevalence was 7%. Eighty-nine percent of the HIV seropositive respondents reported knowing they were HIV seropositive and being on antiretroviral therapy prior to the COVID-19 pandemic. There were two likely seroconversions in 518.83 person-years at risk from the March 2020 start of the pandemic to the times of interviews, for an estimated incidence rate of 0.39/100 person-years, 95% Poisson CI 0.05-1.39/100 person-years. Conclusions There is concern that the COVID-19 pandemic disruptions to HIV prevention services and the psychological stress of the pandemic may lead to increased risk behavior and increased HIV transmission. These data indicate adaptive/resilient behaviors in both obtaining COVID-19 vaccination and maintaining a low rate of HIV transmission among this sample of PWID during the first two years of the COVID-19 pandemic in NYC. | ||
546 | |a EN | ||
690 | |a Persons who inject drugs (PWID) | ||
690 | |a New York City | ||
690 | |a HIV | ||
690 | |a Incidence | ||
690 | |a COVID-19 | ||
690 | |a Vaccination | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Harm Reduction Journal, Vol 20, Iss 1, Pp 1-10 (2023) | |
787 | 0 | |n https://doi.org/10.1186/s12954-023-00791-0 | |
787 | 0 | |n https://doaj.org/toc/1477-7517 | |
856 | 4 | 1 | |u https://doaj.org/article/0b2d77a2515b46cbb0ed69fbe8a5b19f |z Connect to this object online. |